By Jack Ring In their forthcoming paper, Solutions Still Searching for a Problem: A Call for Relevant Data to Support “Evergreening” Allegations,[1] C-IP2 Senior Scholars Erika Lietzan of Mizzou Law […]
[Archived Post] Professors Erika Lietzan and Kristina Acri on “Distorted Drug Patents”
The following post comes from Austin Shaffer, a 2L at Scalia Law and a Research Assistant at CPIP. By Austin Shaffer In their new paper, Distorted Drug Patents, CPIP Senior […]
[Archived Post] CPIP Roundup – October 30, 2020
Greetings from CPIP Executive Director Sean O’Connor With the end of the crazy year of 2020 coming into view, we here at CPIP are striving for a strong finish and […]
[Archived Post] CPIP Roundup – September 30, 2020
Greetings from CPIP Executive Director Sean O’Connor As we move through our busy fall season here at CPIP, we are grateful for the efforts of everyone in the George Mason […]
[Archived Post] CPIP Roundup – August 31, 2020
Greetings from CPIP Executive Director Sean O’Connor August has seen the beginning of a highly unusual school year, but I hope everyone is continuing to stay safe. And, since even […]
[Archived Post] Recent Developments in the Life Sciences: The Continuing Assault on Innovation by Antitrust Plaintiffs in Lantus
By Erika Lietzan In February, the U.S. Court of Appeals for the First Circuit held, in a direct purchaser antitrust action, that an innovative pharmaceutical company marketing an injectable drug […]
[Archived Post] CPIP Roundup – April 30, 2020
Greetings from CPIP Executive Director Sean O’Connor As we move into another month of stay-at-home here in the DMV—and perhaps some re-openings—we here at CPIP hope that you and yours […]
[Archived Post] The Tradeoffs Involved in New Drug Approval, Expanded Access, and Right to Try
The following post comes from CPIP Senior Fellow for Life Sciences Erika Lietzan, and it is cross-posted here from the Objective Intent blog with permission. This note explains some of […]
[Archived Post] CPIP Scholars Join Comment Letter to FTC Supporting Evidence-Based Approach to IP Policymaking
On December 21, 2018, CPIP Senior Scholars Jonathan Barnett, Chris Holman, Erika Lietzan, Adam Mossoff, Sean O’Connor, and Kristen Osenga joined a comment letter that was filed with the FTC […]
[Archived Post] The PTAB’s Regulatory Overreach and How it Cripples the Innovation Economy
On August 14, 2017, the Regulatory Transparency Project of the Federalist Society published a new white paper, Crippling the Innovation Economy: Regulatory Overreach at the Patent Office. This white paper […]